Managing diabetic foot infections: a survey of Australasian infectious diseases clinicians

[1]  A. Macleod.  Australian Health Practitioner Regulation Agency , 2017 .

[2]  D. Dunstan,et al.  The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) , 2001 .

[3]  Lloyd Reed,et al.  Direct inpatient burden caused by foot-related conditions: a multisite point-prevalence study , 2016, BMJ Open.

[4]  W. Jeffcoate,et al.  Interventions in the management of infection in the foot in diabetes: a systematic review , 2016, Diabetes/metabolism research and reviews.

[5]  Benjamin A Lipsky,et al.  IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes , 2016, Diabetes/metabolism research and reviews.

[6]  R. Price,et al.  High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study). , 2015, Diabetes research and clinical practice.

[7]  S. Kuys,et al.  Prevalence of foot disease and risk factors in general inpatient populations: a systematic review and meta-analysis , 2015, BMJ Open.

[8]  M. Maley,et al.  Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes , 2015, Diabetes/metabolism research and reviews.

[9]  Mehrulnisa Alam,et al.  Therapeutic Guidelines: Antibiotic. Version 15. , 2015 .

[10]  Anthony W. Russell,et al.  Reduced Incidence of Foot-Related Hospitalisation and Amputation amongst Persons with Diabetes in Queensland, Australia , 2015, PloS one.

[11]  P. Norman,et al.  Temporal changes in the prevalence and associates of foot ulceration in type 2 diabetes: the Fremantle Diabetes Study. , 2015, Journal of diabetes and its complications.

[12]  R. Murray,et al.  What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  D. Dunstan,et al.  Associations of change in television viewing time with biomarkers of postmenopausal breast cancer risk: the Australian Diabetes, Obesity and Lifestyle Study , 2014, Cancer Causes & Control.

[14]  D. Paterson,et al.  Determining research priorities for clinician‐initiated trials in infectious diseases , 2013, The Medical journal of Australia.

[15]  S. Bergin,et al.  A limb lost every 3 hours: can Australia reduce amputations in people with diabetes? , 2012, The Medical journal of Australia.

[16]  S. Bergin,et al.  Australian Diabetes Foot Network: management of diabetes‐related foot ulceration — a clinical update , 2012, The Medical journal of Australia.

[17]  David G Armstrong,et al.  2012 infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections. , 2013, Journal of the American Podiatric Medical Association.

[18]  M. Kamp,et al.  Standardising practices improves clinical diabetic foot management: the Queensland Diabetic Foot Innovation Project, 2006-09. , 2012, Australian health review : a publication of the Australian Hospital Association.

[19]  W. Jeffcoate,et al.  Expert opinion on the management of infections in the diabetic foot , 2012, Diabetes/metabolism research and reviews.

[20]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.

[21]  B. Allard,et al.  Wound Chronicity, Inpatient Care, and Chronic Kidney Disease Predispose to MRSA Infection in Diabetic Foot Ulcers , 2009, Diabetes Care.

[22]  K. Rerkasem,et al.  Reducing Lower Extremity Amputations Due to Diabetes: The Application of Diabetic-Foot Protocol in Chiang Mai University Hospital , 2008, The international journal of lower extremity wounds.

[23]  J. Rauwerda,et al.  Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000. , 2004, Diabetes care.

[24]  D. Armstrong,et al.  Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. , 2003, Diabetes care.

[25]  A. Boulton,et al.  Methicillin‐resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[26]  R. Horswell,et al.  Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. , 2000, Diabetes care.

[27]  N. Unwin,et al.  Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia , 2000, The British journal of surgery.

[28]  E H Wagner,et al.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes. , 1999, Diabetes care.

[29]  J. Shaw,et al.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. , 2011, Diabetes research and clinical practice.

[30]  The Australasian Society for Infectious Diseases. , 1979, The Medical journal of Australia.